Kawin Technology Overview

  • Founded
  • 2008

  • Status
  • Public

  • Employees
  • 647

  • Stock Symbol
  • 688687

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $2.69

  • (As of Friday Closing)

Kawin Technology General Information


Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Stock Exchange
Primary Office
  • No. 6 Rongjing Street East
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kawin Technology Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.69 $2.66 $2.36 - $4.86 $451M 170M 3.6M $0.10

Kawin Technology Financials Summary

In Thousands,
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 369,366 540,313
Revenue 178,118 177,225 124,780 119,388
EBITDA 15,895 21,412 16,674 12,503
Net Income 17,312 16,616 10,938 7,751
Total Assets 337,727 341,654 179,419 150,428
Total Debt 458 536 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kawin Technology Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Executive Team (2)

Name Title Board Seat Contact Info
Desheng Zhou MD Chairman & General Manager
Yunde Hou Founder
To view Kawin Technology’s complete executive team members history, request access »

Kawin Technology Board Members (6)

Name Representing Role Since
Desheng Zhou MD Kawin Technology Chairman & General Manager 000 0000
Hui Li Self Board Member 000 0000
Liping Zhang Self Board Member 000 0000
Ningning Ma Self Board Member 000 0000
Qingmin Wu Self Co-Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Kawin Technology Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kawin Technology Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 11-Jan-2019 00000 0000 000.00 Biotechnology
Ginkgo 03-Aug-2015 Corporate Drug Discovery
To view Kawin Technology’s complete investments history, request access »